ERYPED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Eryped, and when can generic versions of Eryped launch?
Eryped is a drug marketed by Azurity and is included in two NDAs.
The generic ingredient in ERYPED is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Eryped
A generic version of ERYPED was approved as erythromycin ethylsuccinate by ARBOR PHARMS LLC on December 31st, 1969.
Summary for ERYPED
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 54 |
Clinical Trials: | 1 |
Patent Applications: | 1,779 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ERYPED |
DailyMed Link: | ERYPED at DailyMed |
Recent Clinical Trials for ERYPED
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assouline-Dayan, Yehudith | |
Yehudith Assouline-Dayan |
Pharmacology for ERYPED
Drug Class | Macrolide Antimicrobial Macrolide |
Physiological Effect | Decreased Sebaceous Gland Activity |
Anatomical Therapeutic Chemical (ATC) Classes for ERYPED
US Patents and Regulatory Information for ERYPED
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azurity | ERYPED | erythromycin ethylsuccinate | GRANULE;ORAL | 050207-003 | Mar 30, 1987 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Azurity | ERYPED | erythromycin ethylsuccinate | GRANULE;ORAL | 050207-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Azurity | ERYPED | erythromycin ethylsuccinate | TABLET, CHEWABLE;ORAL | 050297-003 | Jul 5, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |